Results 9,941-9,960 of 21,040 for speaker:Alan Kelly

Select Committee on Health: Health and Social Care Professionals (Amendment) Bill 2017: Committee Stage (11 Jul 2017)

Alan Kelly: I had to get the Minister on the record on this.

Select Committee on Health: Health and Social Care Professionals (Amendment) Bill 2017: Committee Stage (11 Jul 2017)

Alan Kelly: Yes, I will withdraw it now on the basis of the previous discussions and re-enter it on Report Stage.

Select Committee on Health: Health and Social Care Professionals (Amendment) Bill 2017: Committee Stage (11 Jul 2017)

Alan Kelly: I withdraw on my amendment to save but cannot speak for Deputies O'Connell and O'Reilly. Many of these issues are interrelated. Based on what the Minister has said and the spirit in which he has said it, we may put them tabled them on Report Stage. Based on what Deputy Brassil said, I understand that there will be a consultation process with both sides. The draft conclusions which emerge...

Select Committee on Health: Health and Social Care Professionals (Amendment) Bill 2017: Committee Stage (11 Jul 2017)

Alan Kelly: On that basis I withdraw the amendment and reserve the right to retable it on Report Stage.

Written Answers — Department of Health: Hospitals Building Programme (12 Jul 2017)

Alan Kelly: 333. To ask the Minister for Health when work will commence on the building of the new 100 bed unit at St. Patrick’s hospital, Waterford (details supplied); and if he will make a statement on the matter. [33530/17]

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: I will be brief because both of my questions have already been asked. It is not like me to be brief, Chairman.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: I thank the witnesses from both bodies for their honesty in answering our questions, as this is obviously a very emotional topic. I will digress here slightly. There are media reports out today about the drug Entresto. The issues around this particular drug have been talked about for some time now. Seeing as they are here with us today, perhaps the witnesses will clarify the situation...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: Some €120 million over five years for all nine?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: Ultimately, is this a matter for the Department of Health?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: I asked a very specific question. Ultimately, the NCPE has passed these nine drugs. It would cost €120 million over five years, and I thank Mr. Hennessy for clarifying that. The NCPE has gone through its process and the HSE has gone through its process. The matter is now sitting on the Minister's desk. This is not a political attack and I ask that it not be taken that way. I know...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: That is not acceptable. I asked a specific question and I want an answer.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: That is not acceptable.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: As long as the answer is about that drug and Mr. Hennessy does not name it, that is fine.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: Mr. Hennessy still has not answered the question.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: Mr. Hennessy has not. Is this a cost-effective drug as recommended by the NCPE? If so, in that scenario, is that unique? Why has it not been funded?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: Is Mr. Hennessy saying that every drug recommended by NCPE is cost effective?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: Professor Barry does not work for the HSE, so maybe he might elaborate on the questions that I asked, because they do not always have to be answered by the HSE.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: Fair enough.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: Is this cost effective?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (12 Jul 2017)

Alan Kelly: To tease this out, are the witnesses saying that there would be no cost-saving?